PensionDanmark Pensionsforsikringsaktieselskab Cuts Holdings in The Clorox Company $CLX

Key Points

• PensionDanmark cut its Clorox stake by 76.9% in the second quarter, selling 11,740 shares and retaining 3,520 shares valued at approximately $336,000.
• Analysts remain cautious, with 12 Hold ratings and five Sell ratings; Clorox has a consensus rating of “Reduce” and an average price target of $102.40.
• Clorox beat quarterly earnings and revenue estimates, but sales declined 2% year over year. The company raised its quarterly dividend to $1.25 per share, representing a 4.6% yield, although its payout ratio is above 100%.

PensionDanmark Pensionsforsikringsaktieselskab lowered its holdings in The Clorox Company (NYSE:CLX - Free Report) by 76.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,520 shares of the company's stock after selling 11,740 shares during the quarter. PensionDanmark Pensionsforsikringsaktieselskab's holdings in Clorox were worth $336,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. State Street Corp boosted its position in Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company's stock worth $1,039,946,000 after purchasing an additional 282,794 shares in the last quarter. Invesco Ltd. increased its position in Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company's stock worth $492,085,000 after purchasing an additional 884,751 shares in the last quarter. Geode Capital Management LLC raised its stake in Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company's stock valued at $318,613,000 after purchasing an additional 10,060 shares during the last quarter. Van ECK Associates Corp lifted its holdings in Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company's stock valued at $316,244,000 after purchasing an additional 426,433 shares in the last quarter. Finally, Two Sigma Investments LP lifted its holdings in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company's stock valued at $214,564,000 after purchasing an additional 439,797 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

CLX has been the subject of a number of recent research reports. BNP Paribas Exane lowered their price target on shares of Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a report on Monday, July 20th. Barclays restated an "underweight" rating and set a $84.00 target price on shares of Clorox in a research report on Tuesday, August 4th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Clorox in a research note on Friday, July 10th. Morgan Stanley dropped their price objective on shares of Clorox from $110.00 to $97.00 and set an "equal weight" rating for the company in a research note on Friday, May 1st. Finally, Wells Fargo & Company lifted their price objective on Clorox from $95.00 to $102.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 4th. Twelve research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Reduce" and a consensus price target of $102.40.

Clorox Stock Performance

Clorox stock opened at $107.74 on Tuesday. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $128.90. The company has a fifty day moving average price of $96.78 and a two-hundred day moving average price of $103.40. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The company has a market cap of $13.03 billion, a PE ratio of 22.35, a P/E/G ratio of 3.13 and a beta of 0.54.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The business had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the prior year, the firm earned $2.87 EPS. The company's revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Research analysts expect that The Clorox Company will post 5.82 earnings per share for the current year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date is Wednesday, August 12th. This is a positive change from Clorox's previous quarterly dividend of $1.24. Clorox's payout ratio is currently 102.90%.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source